Published in Am Heart J on December 01, 2001
Diagnostic tools for atrial tachyarrhythmias in implantable pacemakers: a review of technical options and pitfalls. Neth Heart J (2008) 0.91
Visualization of elusive structures using intracardiac echocardiography: insights from electrophysiology. Cardiovasc Ultrasound (2004) 0.90
The worldwide social burden of atrial fibrillation: what should be done and where do we go? J Interv Card Electrophysiol (2007) 0.84
Pacing for atrial fibrillation. Heart (2003) 0.82
Future easy and physiological cardiac pacing. World J Cardiol (2011) 0.81
Clinical application of pacemakers in atrial tachyarrhythmias. Neth Heart J (2008) 0.80
Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Interv Card Electrophysiol (2005) 0.77
Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation. J Interv Card Electrophysiol (2014) 0.77
Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study). J Interv Card Electrophysiol (2006) 0.76
Atrial fibrillation and pacing algorithms. Indian Pacing Electrophysiol J (2006) 0.75
Physiological cardiac pacing: Current status. Indian Heart J (2016) 0.75
Devices for prevention of atrial tachyarrhythmias. Indian Pacing Electrophysiol J (2004) 0.75
Hybrid therapy in the management of atrial fibrillation. Curr Cardiol Rev (2015) 0.75
Comparison of the Influence of Right Atrial Septal Pacing and Appendage Pacing on an Atrial Function and Atrial Fibrillation in the Clinical Situation. J Atr Fibrillation (2016) 0.75
The role of pacing in rhythm control and management of atrial fibrillation. J Interv Card Electrophysiol (2007) 0.75
[The role of cardiac pacing in atrial arrhythmia prevention]. Z Kardiol (2005) 0.75
Atrial fibrillation: profit from cardiac pacing? Z Kardiol (2005) 0.75
[Atrial pacing for prevention of atrial fibrillation. Influence of septal atrial pacing, atrial overdrive and AV-delay-optimization on atrial fibrillation burden]. Herzschrittmacherther Elektrophysiol (2009) 0.75
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med (2001) 9.68
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome. Nat Genet (2000) 4.78
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04
Systematic review: Sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther (2014) 2.81
Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J (2002) 2.75
Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci U S A (2000) 2.55
Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol (1998) 2.38
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
Diagnosing syncope in clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial - the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio) Eur Heart J (2000) 2.02
Localized (solitary) fibrous tumors of the pleura: an analysis of 55 patients. Ann Thorac Surg (2000) 1.95
Influence of digital and analogue cellular telephones on implanted pacemakers. Eur Heart J (1997) 1.82
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med (2001) 1.73
Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol (1999) 1.68
Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol (1998) 1.66
Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J (2002) 1.59
Radiofrequency catheter ablation of idiopathic left ventricular outflow tract tachycardia: utility of intracardiac echocardiography. J Cardiovasc Electrophysiol (2001) 1.57
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil (2007) 1.56
Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation (2001) 1.54
Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol (1996) 1.54
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery. Br J Anaesth (2003) 1.49
Characteristics and distribution of spinal focal synaptic potentials generated by group II muscle afferents. Acta Physiol Scand (1974) 1.47
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Improving feasibility of posterior descending coronary artery flow recording by transthoracic Doppler echocardiography. Eur J Echocardiogr (2003) 1.45
Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J (1998) 1.44
Videothoracoscopic treatment of primary spontaneous pneumothorax: a 6-year experience. Ann Thorac Surg (2000) 1.43
Electroencephalographic correlates of vasovagal syncope induced by head-up tilt testing. Stroke (1998) 1.42
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41
Gemcitabine and small cell lung cancer. Lung Cancer (2001) 1.40
Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. G Ital Cardiol (1999) 1.40
Chondroblastoma of the rib presenting as an intrathoracic mass. Report of a case with fine needle aspiration biopsy, immunocytochemistry and electron microscopy. Acta Cytol (1992) 1.39
[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39
Biventricular pacing in patients with heart failure and intraventricular conduction delay: state of the art and perspectives. The European view. Eur Heart J (2002) 1.39
Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol (1986) 1.33
Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation (2001) 1.32
Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. J Clin Oncol (1998) 1.31
Convergence on interneurones mediating the reciprocal Ia inhibition of motoneurones. I. Disynaptic Ia inhibition of Ia inhibitory interneurones. Acta Physiol Scand (1976) 1.29
Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol (1986) 1.29
Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. Am Heart J (2001) 1.28
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol (1999) 1.27
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ Res (2001) 1.26
Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest (2004) 1.25
Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood (1991) 1.23
Malaria in the emergency department. Ann Emerg Med (1983) 1.21
Costello syndrome: further clinical delineation, natural history, genetic definition, and nosology. Am J Med Genet (1993) 1.19
Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry (2008) 1.19
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation (2001) 1.18
Management of atrial fibrillation--what are the possibilities of early detection with home monitoring? Clin Res Cardiol (2006) 1.17
A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. Am Heart J (1999) 1.17
[Cutaneous necrotizing vasculitis caused by immunocomplexes during treatment with levamisole]. Boll Ist Sieroter Milan (1983) 1.14
The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: calendar year 1997--Europe. Pacing Clin Electrophysiol (2001) 1.13
Cervicofacial actinomycosis: still a difficult differential diagnosis. Acta Otorhinolaryngol Ital (2005) 1.13
Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet (2003) 1.12
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry (2001) 1.12
Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection. J Thorac Cardiovasc Surg (2001) 1.11
Alterations in the CSB gene in three Italian patients with the severe form of Cockayne syndrome (CS) but without clinical photosensitivity. Hum Mol Genet (1999) 1.10
NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. Ann Oncol (2006) 1.10
The value of permanent follow-up of implantable pacemakers--first results of an European trial. Biomed Tech (Berl) (2002) 1.10
Osteo-odonto-keratoprosthesis. Description of surgical technique with results in 85 patients. Cornea (1994) 1.09
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09
Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet (2005) 1.09
Variable cerebral dysfunction during tilt induced vasovagal syncope. Pacing Clin Electrophysiol (1998) 1.08
Establishment of a deer mouse (Peromyscus maniculatus rufinus) breeding colony from wild-caught founders: comparison of reproductive performance of wild-caught and laboratory-reared pairs. Comp Med (2001) 1.08
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica (2001) 1.08
"Jnking" atherosclerosis. Cell Mol Life Sci (2005) 1.06
Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum (2002) 1.06
[Guidelines for the use of the implantable defibrillator. Combined task force of the Italian Group of Arrhythmia and the Italian Association of Cardiostimulation]. G Ital Cardiol (1992) 1.06
Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group. Am J Cardiol (2000) 1.06
Do European GSM mobile cellular phones pose a potential risk to pacemaker patients? Pacing Clin Electrophysiol (1995) 1.05
Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation (1998) 1.05
Incidence and etiology of dementia in a large elderly Italian population. Neurology (2005) 1.03
The fine structure of the sympathetic axons within the Pacinian corpuscle. Brain Res (1971) 1.03
beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat (2000) 1.03
Convergence on interneurones mediating the reciprocal Ia inhibition of motoneurones. III. Effects from supraspinal pathways. Acta Physiol Scand (1976) 1.02
Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol (1992) 1.02